Document is current
Any future updates will be listed below
-
Authors
Berry, Parul
Khanna, Sahil https://orcid.org/0000-0002-7619-8338
- License Information
-
More Information
Article History
Accepted: 13 July 2023
First Online: 26 July 2023
Declarations
:
: No sources of funding were received for the preparation of this article.
: Parul Berry has no conflicts of interest that are directly relevant to the content of this article. Sahil Khanna received research grants from Rebiotix, Inc. (a Ferring company), Seres, Finch, Vedanta, and Pfizer and consulting fees from Takeda, Immuron, Niche, and ProbioTech Inc., outside of the submitted work.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Study conception and design: SK; draft manuscript preparation; PB: final draft preparation: SK and PB. All authors read and approved the final manuscript.
